USA —GE HealthCare has announced the acquisition of IMACTIS, a French developer of computed tomography (CT) interventional guidance technology.

The acquisition is the first for the newly independent company, a week after GE completed the spin-off of its healthcare unit.

General Electric still retains a 19.9% stake in GE HealthCare. GE HealthCare has more than four million product installations servicing over two billion patient exams annually.

The transaction’s financial terms were not disclosed, but GE HealthCare stated that it intends to fund the acquisition with cash on hand.

The IMACTIS CT-Navigation system provides stereotactic needle guidance during minimally invasive procedures, allowing for pre-planning and continuous control.

It has received FDA 510(k) clearance, and the system is approved under the Medical Devices Regulation of the European Union.

GE intends to expand the system with its larger image-guided therapy (IGT) business, despite the fact that the technology is currently focused on CT images.

Following the completion of the spinoff, GE HealthCare announced the appointment of Dr. Taha Kass-Hout, formerly of Amazon Web Services, as the company’s first chief technology officer.

It also released preliminary financial results for the fourth quarter and full year. The newly independent company reported US$4.9 billion in fourth-quarter revenue and US$18.3 billion in full-year revenue.

According to GE HealthCare, revenue growth in 2022 was around 4% year on year to US$18.3 billion.

CEO Peter Arduini stated at the annual J.P. Morgan Healthcare Conference that integrating artificial intelligence into its products is a major focus. Mergers and acquisitions will also play an “important role for us in the long run.”

He pointed out that the IMACTIS acquisition was a good example of the company’s M&A strategy because it will provide a feature set that will take GE HealthCare into “a slightly new area while leveraging a core of our capabilities.”

Wipro GE HealthCare names Chaitanya Sarawate as MD of South Asia

Meanwhile, Wipro GE HealthCare has named Chaitanya Sarawate as its new South Asia Managing Director, President, and CEO, effective February 13.

Sarawate’s main responsibilities will be to strengthen the company’s market leadership position in South Asia by driving localization strategy and delivering clinical access and precision care. He will report to Elie Chaillot, President, and CEO, GE HealthCare Intercontinental.

Sarawate is currently the Chief Marketing and Strategy Officer for ASEAN, Korea, Australia (AKA), and New Zealand at GE Healthcare.

He led an organizational transformation that resulted in increased visibility, empowerment, and gains through segment specialization.

Sarawate has over 20 years of corporate and healthcare experience. He has been with GE HealthCare for over 12 years.

For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.